<code id='02A27280FB'></code><style id='02A27280FB'></style>
    • <acronym id='02A27280FB'></acronym>
      <center id='02A27280FB'><center id='02A27280FB'><tfoot id='02A27280FB'></tfoot></center><abbr id='02A27280FB'><dir id='02A27280FB'><tfoot id='02A27280FB'></tfoot><noframes id='02A27280FB'>

    • <optgroup id='02A27280FB'><strike id='02A27280FB'><sup id='02A27280FB'></sup></strike><code id='02A27280FB'></code></optgroup>
        1. <b id='02A27280FB'><label id='02A27280FB'><select id='02A27280FB'><dt id='02A27280FB'><span id='02A27280FB'></span></dt></select></label></b><u id='02A27280FB'></u>
          <i id='02A27280FB'><strike id='02A27280FB'><tt id='02A27280FB'><pre id='02A27280FB'></pre></tt></strike></i>

          leisure time

          leisure time

          author:focus    Page View:7247
          Lauren Gavron walking with prosthetic in a lab at the University of Pittsburgh. Courtesy Nathan Langer/UPMC & Pitt Health Sciences

          For years, Lauren Gavron relied on oxycodone to quiet the pain in her missing lower left limb. But she hated the fog that came with it, preventing her from feeling comfortable enough to drive.

          When researchers at the University of Pittsburgh delivered electric jolts to her spine in 2021, the Duquesne, Pennsylvania resident was shocked to feel that pain temporarily melt away — and to feel sensation in her prosthetic foot, improving her walk and balance.

          advertisement

          “You really wouldn’t believe it,” Gavron, 67, said. “As soon as the pain would start, it just all went away.”

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Medicare details structure of new drug price negotiation program
          Medicare details structure of new drug price negotiation program

          MedicareonFridayreleasednewdetailsabouthowitsnewdrugpricenegotiationprogramwillwork,justtwomonthsbef

          read more
          Readout Newsletter: The latest from Bristol, Sarepta, and Novartis
          Readout Newsletter: The latest from Bristol, Sarepta, and Novartis

          CourtesyBristolMyersSquibbWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup togetour

          read more
          ChatGPT in medicine: STAT answers readers' burning questions
          ChatGPT in medicine: STAT answers readers' burning questions

          MikeReddyforSTATArtificialintelligenceisoftendescribedasablackbox:anunknowable,mysteriousforcethatop

          read more

          The Karikó problem: Lessons for funding basic research

          AdobeNewscientificinstitutesarespringingupallovertheplacethesedays:ArcadiaScience,NewScience,ArcInst